...Predictive biomarkers for survival benefit with ramucirumab in urothelial cancer in the RANGE trial.....
https://eipm.weill.cornell.edu/publications?page=26&s=type&o=asc
...Predictive biomarkers for survival benefit with ramucirumab in urothelial cancer in the RANGE trial.....
https://eipm.weill.cornell.edu/publications?page=26&s=title&o=asc
...Consistent survival benefit of enzalutamide plus androgen deprivation therapy in men with nonmetastatic...
https://eipm.weill.cornell.edu/publications?page=22&s=year&o=desc
...Predictive biomarkers for survival benefit with ramucirumab in urothelial cancer in the RANGE trial.....
https://eipm.weill.cornell.edu/publications?page=19&s=year&o=desc
...Predictive biomarkers for survival benefit with ramucirumab in urothelial cancer in the RANGE trial.....
https://eipm.weill.cornell.edu/publications?page=10&s=type&o=desc
...Consistent survival benefit of enzalutamide plus androgen deprivation therapy in men with nonmetastatic...
https://eipm.weill.cornell.edu/publications?page=10&s=year&o=asc
...Predictive biomarkers for survival benefit with ramucirumab in urothelial cancer in the RANGE trial.....
https://eipm.weill.cornell.edu/publications?page=19
...Consistent survival benefit of enzalutamide plus androgen deprivation therapy in men with nonmetastatic...
https://eipm.weill.cornell.edu/publications?page=22
...Our Program menu options Pediatric Transition Adult For PatientsToggle For Patients menu options Benefits...
https://thalassemia.weill.cornell.edu/about-us/news-announcements/conferences-meetings
...Initiatives Locations Contact Us WCM EEO Statement Why Choose UsToggle Why Choose Us menu options Benefits...
https://careers.weill.cornell.edu/why-choose-us/employee-profiles/nadeige
